MBIO
Companies
NASDAQ
Mustang Bio Inc.
Health Care
$1.07
-$7.79 (-87.97%)
Price Chart
Overview
About MBIO
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Market Cap
$1.9M
Volume
154.2K
Avg. Volume
806.1K
P/E Ratio
-3.5428572
Dividend Yield
0.00%
Employees
97.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.80
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, MBIO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.9M
Volume154.2K
P/E Ratio-3.54
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 28, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025